Search results for: Daniel Kahneman
Filter search results
Kahneman’s legacy in health economics
4 April 2024
…In this case, based on Kahneman’s research, we may be better off focusing on life satisfaction. Daniel Kahneman’s research has had a substantial impact on the field of health economics,…
Daniel Ollendorf
3 February 2023
Dan Ollendorf is Chief Scientific Officer and Director of HTA Methods and Engagement at the Institute for Clinical and Economic Review (ICER). An internationally recognized expert in health technology assessment…
QALYs versus Experience: A Perspective from Experimental Economics
1 August 2008
OHE’s 14th Annual Lecture was delivered by Professor Daniel Kahneman, winner of the 2002 Nobel Prize in Economic Sciences for his pioneering work integrating insights from psychological research into economic…
OHE at Priorities 2016: Valuing Health at the End of Life and MCDA for Priority Setting
19 September 2016
…by Rob Baltussen, with Mireille Goetghebeur (University of Montreal) and Norman Daniels (Harvard School of Public Health) as contributors. The session: provided an overview on the use of multi-criteria decision…
OHE at ISPOR Europe 2016: Risk-sharing, Differential Pricing, the Cancer Drugs Fund, and Patient Reported Outcomes
26 October 2016
…Drugs and Other Medical Products. Sunday, 8:00-12:00, Hall F1 (L0), pre-registration is required. Course tutors: Lou Garrison (University of Washington and OHE), Adrian Towse (OHE), Paolo Daniele Siviero (Principia III)….
HTA and Payment Mechanisms for New Drugs to Tackle AMR
23 September 2019
…be sold after patent expiry when the product is priced as a generic. Daniel et al. (2017) have proposed an alternative contracting approach for antibiotics called the Priority Antimicrobial Value…
Our governance and network
…Mike Drummond Hareth Al-Janabi Policy committee Anita Charlesworth Neil McAuslane Meindert Boysen Tom Easterling Daniel Ollendorf Siva Anandaciva Elliot Dunster Neil Grubert Editorial panel Julie Ratcliffe Peter Zweifel John Brazier…